- Type / Class
- Equity / Common Stock
- Shares outstanding
- 131,262,829
- Total 13F shares
- 124,295,969
- Share change
- +6,115,155
- Total reported value
- $6,467,826,507
- Put/Call ratio
- 155%
- Price per share
- $52.04
- Number of holders
- 359
- Value change
- +$330,760,770
- Number of buys
- 193
- Number of sells
- 157
Quarterly Holders Quick Answers
What is CUSIP 40131M109?
CUSIP 40131M109 identifies GH - Guardant Health, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 40131M109:
Top shareholders of GH - Guardant Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
9.2%
|
12,081,377
|
$514,666,661 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.5%
from 13D/G
|
11,173,880
|
$476,007,288 | — | 31 Mar 2025 | |
| Deep Track Capital, LP |
13D/G
13F
|
Company |
4.4%
|
5,443,721
|
$269,627,501 | $0 | 31 Mar 2025 | |
| CADIAN CAPITAL MANAGEMENT, LP |
13D/G
13F
|
Company |
4.2%
|
5,221,565
|
$258,624,114 | $0 | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
13F
|
Company |
3.9%
|
4,850,271
|
$240,233,923 | $0 | 31 Dec 2024 | |
| Capital International Investors |
13F
|
Company |
3.9%
|
5,147,724
|
$219,293,042 | — | 31 Mar 2025 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
3.9%
|
5,061,011
|
$215,599,068 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.7%
|
3,596,913
|
$153,228,494 | — | 31 Mar 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.7%
|
3,566,738
|
$151,952,597 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,907,626
|
$123,893,362 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
2,800,039
|
$119,281,661 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
2.1%
|
2,794,667
|
$119,052,814 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
2.1%
|
2,777,040
|
$118,301,904 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.8%
|
2,367,800
|
$100,868,280 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
1.7%
|
2,281,061
|
$97,173,198 | — | 31 Mar 2025 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
1.5%
|
1,965,721
|
$83,739,716 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.5%
|
1,933,086
|
$82,349,464 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.4%
|
1,825,863
|
$77,781,764 | — | 31 Mar 2025 | |
| ARK Investment Management LLC |
13F
|
Company |
1.1%
|
1,409,116
|
$60,028,327 | — | 31 Mar 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1%
|
1,357,227
|
$57,817,870 | — | 31 Mar 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
1%
|
1,356,990
|
$57,767,064 | — | 31 Mar 2025 | |
| BRAIDWELL LP |
13F
|
Company |
1%
|
1,327,327
|
$56,544,130 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.99%
|
1,301,803
|
$55,456,808 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.97%
|
1,277,280
|
$54,412,128 | — | 31 Mar 2025 | |
| NORGES BANK |
13F
|
Company |
0.92%
|
1,212,766
|
$51,663,832 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.89%
|
1,167,282
|
$49,726,213 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.84%
|
1,096,733
|
$46,720,826 | — | 31 Mar 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.8%
|
1,050,821
|
$44,764,975 | — | 31 Mar 2025 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.8%
|
1,044,097
|
$44,478,532 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.76%
|
996,506
|
$42,451,174 | — | 31 Mar 2025 | |
| Aristotle Atlantic Partners, LLC |
13F
|
Company |
0.73%
|
964,521
|
$41,088,595 | — | 31 Mar 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.73%
|
954,493
|
$40,661,000 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.72%
|
940,505
|
$40,065,529 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.65%
|
852,052
|
$36,297,440 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.65%
|
850,009
|
$36,210,383 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.65%
|
846,749
|
$36,071,507 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.64%
|
838,992
|
$35,741,059 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.59%
|
776,570
|
$33,081,894 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.57%
|
746,636
|
$31,806,693 | — | 31 Mar 2025 | |
| Blue Water Life Science Advisors, LP |
13F
|
Company |
0.53%
|
694,047
|
$29,566,402 | — | 31 Mar 2025 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.49%
|
638,600
|
$27,225,204 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.48%
|
629,508
|
$26,818,000 | — | 31 Mar 2025 | |
| Railway Pension Investments Ltd |
13F
|
Company |
0.47%
|
620,878
|
$26,449,403 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.47%
|
616,500
|
$26,262,900 | — | 31 Mar 2025 | |
| Iron Triangle Partners LP |
13F
|
Company |
0.46%
|
600,867
|
$25,596,934 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.44%
|
578,346
|
$24,637,540 | — | 31 Mar 2025 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.4%
|
531,424
|
$22,638,662 | — | 31 Mar 2025 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.4%
|
525,702
|
$22,394,905 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.38%
|
498,129
|
$21,220,296 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.37%
|
489,929
|
$20,870,970 | — | 31 Mar 2025 |
Institutional Holders of Guardant Health, Inc. - Common Stock (GH) as of Q2 2025
As of 30 Jun 2025,
Guardant Health, Inc. - Common Stock (GH) was held by
359 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
124,295,969 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., Capital International Investors, BAILLIE GIFFORD & CO, Deep Track Capital, LP, Invesco Ltd., EVENTIDE ASSET MANAGEMENT, LLC, CADIAN CAPITAL MANAGEMENT, LP, CITADEL ADVISORS LLC, and UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC.
This page lists
362
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
336
Q2 2025 holders
359
Holder diff
23
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.